|Videos|May 30, 2023
CAR-T Cell Therapies Entering the Mainstream of Cancer Clinical Trials & Treatment
Author(s)Medidata
KEY LEARNING OBJECTIVES
- Audience will have an understanding how Medidata can have an impact with Clinical Trial pharma and bio tech firms that are working in this therapeutic area
- What are the challenges that CAR-T developers face and how can data help address those challenges
- How is Medidata AI “data” different from other data providers
Related Content
Trending on Applied Clinical Trials Online
1
ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access
2
Artificial Intelligence in Clinical Trials: From Pilots to Practice
3
Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection
4
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
5